BIO Investor Forum

You've probably heard the term "pandemic" a lot in the news today.  What you might not know is that biotechnology researchers are working to create new vaccination options to help stop the next big pandemic before it starts.  Join Dr.

The Burrill Report’s Daniel Levine spoke with Jim Greenwood, president and CEO of BIO, about the upcoming Eighth Annual BIO Investor Forum’s opening plenary session on healthcare reform. Greenwood will be moderating the session, “Healthcare Reform: Sustaining Biotech Innovation in a New World.”


Listen to the podcast

Tracy Krughoff talks with John Craighead about the BIO Investor Forum.
Learn about the meeting and listen to the podcast.

Tracy Krughoff of BIO talks to Barry Greene, president and COO of Alnylam Pharmaceuticals (ALNY) at the Seventh Annual BIO Investor Forum in San Francisco. Alnylam has developed a deep pipeline of drug products to treat a multitude of diseases through RNAi therapeutics.

Listen to the podcast

Moments ago, panelists at the opening plenary painted a startlingly realistic picture of the industry, but emphasized that this is the time for companies to be more aggressive and strategic in how they target and approach potential investors and partners.